Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
We present the case of a patient with an elevated prostate-specific antigen level who underwent a prostate MRI that revealed a mass between the prostate and rectum, prompting further evaluation.
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results